secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001493152-23-039514
Event type: debt
Sentiment:  neutral
Materiality: 0.45
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX draws remaining $500K under secured note with Juvenescence; repayment due Feb 14, 2024
--------------------------------------------------------------------------------

- Drew $500,000 from Amended Secured Convertible Promissory Note on Oct 31, 2023.
- Repayment date for outstanding principal is February 14, 2024.
- Negotiating an increase in the Secured Note line of credit with Juvenescence.
- Previously disclosed material terms in 10-Q filed May 12, 2023 and 8-Ks filed June 8 and Aug 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223039514/0001493152-23-039514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223039514/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer